Publications by authors named "A Lavole"

Claim this Profile
S
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.
Lambert Assoumou, Raghiatou Baldé, Christine Katlama, Baptiste Abbar, Pierre Delobel, Armelle Lavole

J Immunother Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO).
Marie Wislez, Julien Mazieres, Armelle Lavole, Gérard Zalcman, Olivier Carre

J Immunother Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer.
Marine Baron, Cathia Soulié, Armelle Lavolé, Lambert Assoumou, Baptiste Abbar

Cells· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Cecile Le Pechoux, Nicolas Pourel, Fabrice Barlesi, Delphine Lerouge, Delphine Antoni, Armelle Lavole

Lancet Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report of Anti-Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy.
Lise Bertin, Anthony Canellas, Baptiste Abbar, Marianne Veyri, Jean-Philippe Spano

JTO Clin Res Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis